Clinical and cost implications of deferred testing in low-risk patients with stable chest pain: a simulation using the PROMISE trial.
Publication
, Journal Article
Nanna, MG; Yow, E; Vemulapalli, S; Mark, DB; Kelsey, M; Patel, MR; Al-Khalidi, HR; Rogers, C; Udelson, JE; Douglas, PS
Published in: Am Heart J
July 2023
Current guidelines recommend a deferred testing approach in low-risk patients presenting with stable chest pain. After simulating a deferred testing approach using the PROMISE Minimal Risk Score to identify 915 minimal risk participants with cost data from the PROMISE trial, a deferred testing strategy was associated with an adjusted cost savings of -$748.74 (95% CI: -1646.97, 158.06) per participant and 74.6% of samples had better clinical outcomes and lower mean cost. This supports the current guideline recommended deferred testing approach in low-risk patients with stable chest pain.
Duke Scholars
Published In
Am Heart J
DOI
EISSN
1097-6744
Publication Date
July 2023
Volume
261
Start / End Page
124 / 126
Location
United States
Related Subject Headings
- Risk Factors
- Humans
- Coronary Angiography
- Chest Pain
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Nanna, M. G., Yow, E., Vemulapalli, S., Mark, D. B., Kelsey, M., Patel, M. R., … Douglas, P. S. (2023). Clinical and cost implications of deferred testing in low-risk patients with stable chest pain: a simulation using the PROMISE trial. Am Heart J, 261, 124–126. https://doi.org/10.1016/j.ahj.2023.02.010
Nanna, Michael G., Eric Yow, Sreekanth Vemulapalli, Daniel B. Mark, Michelle Kelsey, Manesh R. Patel, Hussein R. Al-Khalidi, Campbell Rogers, James E. Udelson, and Pamela S. Douglas. “Clinical and cost implications of deferred testing in low-risk patients with stable chest pain: a simulation using the PROMISE trial.” Am Heart J 261 (July 2023): 124–26. https://doi.org/10.1016/j.ahj.2023.02.010.
Nanna MG, Yow E, Vemulapalli S, Mark DB, Kelsey M, Patel MR, et al. Clinical and cost implications of deferred testing in low-risk patients with stable chest pain: a simulation using the PROMISE trial. Am Heart J. 2023 Jul;261:124–6.
Nanna, Michael G., et al. “Clinical and cost implications of deferred testing in low-risk patients with stable chest pain: a simulation using the PROMISE trial.” Am Heart J, vol. 261, July 2023, pp. 124–26. Pubmed, doi:10.1016/j.ahj.2023.02.010.
Nanna MG, Yow E, Vemulapalli S, Mark DB, Kelsey M, Patel MR, Al-Khalidi HR, Rogers C, Udelson JE, Douglas PS. Clinical and cost implications of deferred testing in low-risk patients with stable chest pain: a simulation using the PROMISE trial. Am Heart J. 2023 Jul;261:124–126.
Published In
Am Heart J
DOI
EISSN
1097-6744
Publication Date
July 2023
Volume
261
Start / End Page
124 / 126
Location
United States
Related Subject Headings
- Risk Factors
- Humans
- Coronary Angiography
- Chest Pain
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology